Sort
17,288 grants matching “multiple sclerosis”
Mobilizing Adult Neural Stem Cells and Disease Models
$435,353Paul H Patterson · California Institute Of Technology · R01 · FY2010 · NS
A Multi-Site Trial of a Cognitive Rehabilitation Intervention for Persons with MS
$435,325Alexa K Stuifbergen · University Of Texas At Austin · R01 · FY2015 · NR
AhR ligands in epigenetic dysregulation of T cells
$435,108Mitzi Nagarkatti · University Of South Carolina At Columbia · R01 · FY2021 · AI
T:B Collaboration and Induction of Autoimmune Tissue Inflammation
$435,015Vijay K Kuchroo · Dana-Farber Cancer Inst · P01 · FY2014 · AI
Regulation of chromatin modifications by miRNAs to control cytokine expression
$435,000To-Ha Thai · Beth Israel Deaconess Medical Center · R56 · FY2012 · AI
Deciphering MDSC function for GBM targeting
$434,936Justin D. Lathia · Cleveland Clinic Lerner Com-Cwru · R01 · FY2021 · NS
Protein homeostasis in a frontotemporal dementia iPSC model
$434,890Charleen T Chu · University Of Pittsburgh At Pittsburgh · R21 · FY2022 · AG
Role of Tim-3:Bat-3 pathway in inducing tolerogenic DCs and peripheral tolerance
$434,860Vijay K Kuchroo · Brigham And Women'S Hospital · R01 · FY2020 · AI
Development of Drugs that Modify CNS Innate Immunity for the Treatment of Multiple Sclerosis
$434,860Francisco J. Quintana · Brigham And Women'S Hospital · R33 · FY2025 · NS
Role of Tim-3:Bat-3 pathway in inducing tolerogenic DCs and peripheral tolerance
$434,860Vijay K Kuchroo · Brigham And Women'S Hospital · R01 · FY2021 · AI
Role of Tim-3:Bat-3 pathway in inducing tolerogenic DCs and peripheral tolerance
$434,860Vijay K Kuchroo · Brigham And Women'S Hospital · R01 · FY2024 · AI
Role of Tim-3:Bat-3 pathway in inducing tolerogenic DCs and peripheral tolerance
$434,860Vijay K Kuchroo · Brigham And Women'S Hospital · R01 · FY2023 · AI
Development of Drugs that Modify CNS Innate Immunity for the Treatment of Multiple Sclerosis
$434,860Francisco J. Quintana · Brigham And Women'S Hospital · R61 · FY2023 · NS
Role of Tim-3:Bat-3 pathway in inducing tolerogenic DCs and peripheral tolerance
$434,860Vijay K Kuchroo · Brigham And Women'S Hospital · R01 · FY2022 · AI
Development of drugs that modify CNS innate immunity for the treatment of Multiple Sclerosis
$434,860Francisco J. Quintana · Brigham And Women'S Hospital · R61 · FY2022 · NS
FDRC1 and Follicular Dendritic Cell Signaling Pathways
$434,693Edward A Clark · University Of Washington · R37 · FY2009 · AI
Pregnancy, Microchimerism, and Autoimmune Disease
$434,634J. Lee Lee Nelson · Fred Hutchinson Cancer Research Center · R01 · FY2009 · AI
Lymphangiogenesis in chronic brain infection
$434,618Tajie H. Harris · University Of Virginia · R21 · FY2022 · NS
Defining The Mechanisms by Which NEK1 Genetic Variants Associated with ALS Patient Motor Neurons Lead to Motor Neuron Degeneration
$434,500Evangelos Kiskinis · Northwestern University At Chicago · R21 · FY2019 · NS
Enhancing Bone Marrow Transplantation With Highly Engraftable Hematopoietic Stem Cells
$434,403Jonathan George Hoggatt · Massachusetts General Hospital · R01 · FY2021 · HL
From single molecule to microfluidic 3D tissue platforms: novel multiscale tools to investigate hyper-stimulated immune cells in the circulation
$434,365Dana M Spence · Michigan State University · R01 · FY2018 · NS
Activation of Macrophages in Human Autoimmune Diseases
$434,363Lionel B Ivashkiv · Hospital For Special Surgery · R01 · FY2014 · AI
Activation of Macrophages in Human Autoimmune Diseases
$434,363Lionel B Ivashkiv · Hospital For Special Surgery · R01 · FY2012 · AI
Activation of Macrophages in Human Autoimmune Diseases
$434,363Lionel B Ivashkiv · Hospital For Special Surgery · R01 · FY2011 · AI
Resource for Nonhuman Primate Immune Reagents
$434,234Francois J Villinger · University Of Louisiana At Lafayette · R24 · FY2025 · OD